EOM Pharmaceuticals Holdings, Inc. IMUC
Set alert
0.07 USD 0.00 -2.67%
At close · Oct 30
0.0726 Day range 0.0726
0.02 52-week range 0.27
- YTD
- +2.82%
- 1 year
- -59.44%
- Open
- 0.0726
- Prev close
- 0.075
- Mkt cap
- 9.23M
- Vol
- 180
- Avg vol
- 1.73K
- EPS
- 1.00
- P/E
- 0.07
- Div yield
- 0.00%
More statistics
- Low
- 0.0726
- High
- 0.0726
- Forward P/E
- -0.05
- Beta
- 2.71
- Short ratio
- 8.46
- Inst. own
- 4.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 30, 2019
- 50-d avg
- 0.108512
- 200-d avg
- 0.212253
- 1y target
- 5.00
6M chart
Signals (57)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 2026 | 3 days ago |
| SMA: Bearish | Oct 27, 2026 | 5 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 22, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 3, 2026 | 5 months ago |
| RSI: Overbought | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 15, 2026 | 5 months ago |
| MACD: Sell Signal | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
Key statistics
- Market cap
- 1.34M
- Enterprise value
- -1.34M
- Trailing P/E
- 0.00
- Forward P/E
- -0.05
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.39
- EPS (TTM)
- -0.269
- Beta
- 2.71
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -9.22M
- Total cash
- 2.85M
- Total debt
- 0
- Return on equity
- -2312.00%
- Shares outstanding
- 41.94M
- Short % of float
- 4.15%
- 50-day average
- 0.108512
- 200-day average
- 0.212253
Analyst view
Consensus: hold
Hold
Price target (mean) 5.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 30, 2019
Expected Nov 30, 2019. Consensus EPS estimate 0.00.
Financials — quick view
IMUC Revenue — quarterly 0
IMUC Net income — quarterly -306.70K
IMUC EPS — quarterly -0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 30, 2019 | Dec 1, 2013 | 0.00 | — | — | — |
| Aug 13, 2018 | Jun 1, 2018 | 0.00 | -0.10 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 10, 2016 | Maxim Group | down | — | Hold |
| Dec 11, 2013 | McNicoll Lewis Vlak | down | — | Hold |
| Dec 11, 2013 | Roth Capital | down | — | Neutral |
About EOM Pharmaceuticals Holdings, Inc.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- imuc.com
News
- EOM Pharmaceutical (OTCMKTS:IMUC) & Siga Technologies (NASDAQ:SIGA) Financial Survey
- EOM Pharmaceutical (OTCMKTS:IMUC) Trading 139% Higher – Still a Buy?
- EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
- EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
- ImmunoCellular Therapeutics Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market
- Morning Market Gainers
Your note
Sign in to keep a note on IMUC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| YU JOHN S | Director | Stock Award(Grant) | Jun 5, 2018 | 120,508 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 2.57% | 1,078,404 | 280.38K | Jun 29, 2018 |
| Vanguard Group, Inc. (The) | 0.68% | 285,154 | 74.14K | Jun 29, 2018 |
| Citadel Advisors LLC | 0.32% | 136,043 | 35.37K | Jun 29, 2018 |
| Virtu Financial LLC | 0.30% | 124,195 | 32.29K | Jun 29, 2018 |
| Wedbush Securities Inc | 0.21% | 86,530 | 22.50K | Jun 29, 2018 |
| First Allied Advisory Services, Inc. | 0.10% | 40,000 | 10.40K | Jun 29, 2018 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Invesco ETF Tr-Invesco Wilshire Micro Cap ETF | 0.03% | 12,365 | 3.21K | Jun 29, 2018 |
| Fidelity Extended Market Index Fund | 0.02% | 6,339 | 1.65K | Jun 29, 2018 |